ArticleGlycoconjugate journal2015
Chemical modification, characterization and bioactivity of a released exopolysaccharide (r-EPS1) from Lactobacillus plantarum 70810.
Article in Glycoconjugate journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Exploration of Exopolysaccharide fromPolymers · 2024Article
- Chemical modification of bacterial exopolysaccharides: Antioxidant properties and health potentials.Current research in food science · 2024Review
- Evaluation of improved biological properties of chemically modified exopolysaccharides from3 Biotech · 2023Article
- Marine Microbial Polysaccharides: An Untapped Resource for Biotechnological Applications.Marine drugs · 2023Review
- Optimization of Exopolysaccharide Produced byFoods (Basel, Switzerland) · 2023Article
- Contribution of Quercetin to the Composition and Antioxidant Properties ofFoods (Basel, Switzerland) · 2023Article
- Extraction optimization, structure features, and bioactivities of two polysaccharides from Corydalis decumbens.PloS one · 2023Article
- Rhizobia exopolysaccharides: promising biopolymers for use in the formulation of plant inoculants.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022Article
- Characterization and Biological Activity of a Novel Exopolysaccharide Produced byMicroorganisms · 2021Article
- Effect of Gamma Irradiation on Enhanced Biological Activities of Exopolysaccharide fromPolymers · 2021Article
- Characterization, the Antioxidant and Antimicrobial Activity of Exopolysaccharide Isolated from Poultry Origin Lactobacilli.Probiotics and antimicrobial proteins · 2019Article
- Structural characterization of a novel polysaccharide from Sargassum thunbergii and its antioxidant and anti-inflammation effects.PloS one · 2019Article
- Bioactive Mushroom Polysaccharides: A Review on Monosaccharide Composition, Biosynthesis and Regulation.Molecules (Basel, Switzerland) · 2017Review
- Quantitative Structure Activity Relationship Models for the Antioxidant Activity of Polysaccharides.PloS oneArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the present study, a released exopolysaccharide (r-EPS1) from L. plantarum 70810 was modified by acetylation, phosphorylation and carboxymethylation. Scanning electron micrograph (SEM) and thermogravimetric analysis (TGA) showed the r-EPS1 derivatives had different surface morphology and thermal behavior. Compared with r-EPS1, the derivatives exhibited stronger antioxidant and antitumor activities. The study provided experimental evidences that chemical modification could be an effective way to improve the bioactivity of exopolysaccharide from L. plantarum 70810. It is noted that these derivatives could be explored as novel potential antioxidant and antitumor agents.
Indexed as
Identifiers
25417068What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.